WMS 2026 Functional and safety outcomes up to 3 years post infusion in the EMBARK study

Sarepta Therapeutics Inc. published this content on September 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2026 at 15:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]